UNSPSC 85531529: Occlusion of left femoral vein with extraluminal device, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left femoral vein with extraluminal device, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06LN0CZ

UNSPSC 85531529, Occlusion of left femoral vein with extraluminal device, open approach, is a Commodity code whose nominal designation does not align with recent state and local procurement activity posted under this code. The recent opportunities tagged to this code span occupational medical surveillance, disability medical evaluations, pharmacy benefit management, surgical carve-out networks, and temporary health professional staffing—none of which involve vascular or surgical device implantation. This mismatch suggests either systematic miscoding in the source data or that the code is not actively used by state and local procurement offices for its intended scope. No evidence of relevant recent solicitations targeting vascular occlusion devices or related orthopedic or vascular surgery products and services appears in the available opportunities.

The issuing bodies posting under this code include state agencies (Washington State Department of Transportation, Washington State Ferries), counties (Harris County, Collier County, Santa Clara County), cities (Phoenix, Long Beach), and county health systems. Geographic activity spans Arizona, California, Florida, Texas, and Washington. Representative recent opportunities include the Washington State Department of Transportation's RFP 20260825 for occupational medical surveillance services (response due October 9, 2026), the City of Phoenix Retirement Office's RFP 26001 for independent medical evaluation services (response due October 16, 2026), and Collier County's RFP 25-8414 for pharmacy benefit management services (response due April 9, 2026). No active state or local procurement activity for vascular or surgical occlusion devices appears supported by the source.